Role of 2D shear wave elastography in differentiating malignancy from focal liver lesions as compared to multiphasic contrast enhanced computed tomography

Krishna Pratap Singh Senger; Rameez Akhand; K. Uday Bhanu; Ankita Singh; D. Mulajkar

doi:10.18203/2320-6012.ijrms20263278

Authors

Krishna Pratap Singh Senger Department of Radiology and Intervention, AICTS, Pune, Maharashtra, India
Rameez Akhand Department of Radiology, CHEC, Kolkata, West Bengal, India
K. Uday Bhanu Department of Radiology, CHEC, Kolkata, West Bengal, India
Ankita Singh AHAD-AP, Kolkata, West Bengal, India
D. Mulajkar Department of Oncology, CHEC, Kolkata, West Bengal, India

DOI:

https://doi.org/10.18203/2320-6012.ijrms20263278

Keywords:

2D SWS, Multiphasic CECT, HCC, FNH, Hemangioma, Metastasis

Abstract

Background: Liver cancer is the third most common cause of cancer mortality worldwide. A precise evaluation of benign and malignant liver lesions is very important for the patients. In the present study, we aim to evaluate the use of SWE in the differentiation of malignant from benign focal liver lesions and to determine the SWE characteristics of common liver lesions as compared to multiphasic computed tomography (CT) scan.

Methods: Diagnostic test evaluation observational study where sensitivity, specificity, PPV and NPV of both modalities 2D SWS and multiphase contrast-enhanced-computed tomography (CECT) are compared. 63 patients with focal liver lesions were evaluated by both modalities with HPE as gold standard.

Results: Overall sensitivity, specificity, PPV, NPV and accuracy of multiphasic CECT is 89.74%, 50.00%, 10.28%, 99.39% and 98.71% respectively. Overall sensitivity, specificity, PPV, NPV and accuracy of 2D SWS is 94.59%, 56.25%, 12.13%, 99.39% and 58.55% respectively.

Conclusions: 2D SWS is a useful modality and is capable of evaluating stiffness changes in the liver associated with solid focal liver lesions, which helps in distinguishing benign from malignant lesions and also in their sub-categorization, i.e., differentiating focal nodular hyperplasia from hemangioma and differentiating hepatocellular carcinoma, with high sensitivity and accuracy. Overall performance of both CECT and 2D SWS did not show much difference statistically. However, both modalities complement each other and shortcoming of one modality can be overcome with the help of other thereby leading to better diagnostic evaluation.

References

Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA. 2018;68(6):394-424.

El-Serag HB. Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology. 2012;142(6):1264-73.

Rockey DC, Caldwell SH, Goodman ZD, Nelson RC, Smith AD. Liver biopsy. Hepatology. 2009;49(3):1017-44.

Forner A, Vilana R, Ayuso C, Bianchi L, Solé M, Ayuso JR, et al. Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma. Hepatology. 2008;47(1):97-104.

Ophir J, Cespedes I, Ponnekanti H, Yazdi Y, Li X. Elastography: a quantitative method for imaging the elasticity of biological tissues. Ultrasonic Imaging. 1991;13(2):111-34.

Strobel D, Seitz K, Blank W, Schuler A, Dietrich C, von Herbay A, et al. Contrast-enhanced ultrasound for the characterization of focal liver lesions-diagnostic accuracy in clinical practice (DEGUM multicenter trial). Eur J Ultrasound. 2008;29(05):499-505.

Ophir J, Cespedes I, Ponnekanti H, Yazdi Y, Li X. Elastography: a quantitative method for imaging the elasticity of biological tissues. Ultrasonic Imaging. 1991;13(2):111-34.

Park JR. Metadata quality in digital repositories: A survey of the current state of the art. Cataloging Classification Quarterly. 2009;47(3-4):213-28.

Gerber L, Fitting D, Srikantharajah K, Weiler N, Kyriakidou G, Bojunga J, et al. Evaluation of 2D-shear wave elastography for characterisation of focal liver lesions. J Gastrointest Liver Dis. 2017;26(3):10.

Laghi A. Multidetector CT (64 Slices) of the liver: examination techniques. Eur Radiol. 2007;17(3):675-83.

Weg N, Scheer MR, Gabor MP. Liver lesions: improved detection with dual-detector-array CT and routine 2.5-mm thin collimation. Radiology. 1998;209(2):417-26.

Schima W, Hammerstingl R, Catalano C, Marti-Bonmati L, Rummeny EJ, Montero FT, et al. Quadruple-phase MDCT of the liver in patients with suspected hepatocellular carcinoma: effect of contrast material flow rate. Am J Roentgenol. 2006;186(6):1571-9.

May MS, Wüst W, Brand M, Stahl C, Allmendinger T, Schmidt B, et al. Dose reduction in abdominal computed tomography: intraindividual comparison of image quality of full-dose standard and half-dose iterative reconstructions with dual-source computed tomography. Investigative Radiol. 2011;46(7):465-70.

Lee MH, Kim YK, Park MJ, Hwang J, Kim SH, Lee WJ, et al. Gadoxetic acid‐enhanced fat suppressed three‐dimensional T1‐weighted MRI using a multiecho dixon technique at 3 tesla: Emphasis on image quality and hepatocellular carcinoma detection. J Magnetic Resonance Imaging. 2013;38(2):401-10.

Oudkerk M, Torres CG, Song B, König M, Grimm J, Fernandez-Cuadrado J, et al. Characterization of liver lesions with mangafodipir trisodium-enhanced MR imaging: multicenter study comparing MR and dual-phase spiral CT. Radiology. 2002;223(2):517-24.

Oto A, Kulkarni K, Nishikawa R, Baron RL. Contrast enhancement of hepatic hemangiomas on multiphase MDCT: can we diagnose hepatic hemangiomas by comparing enhancement with blood pool? Am J Roentgenol. 2010;195(2):381-6.

Uggowitzer MM, Kugler C, Mischinger HJ, Gröll R, Ruppert-Kohlmayr A, Preidler KW, et al. Echo‐enhanced Doppler sonography of focal nodular hyperplasia of the liver. J Ultrasound Med. 1999;18(7):445-51.

Mathieu D, Kobeiter H, Maison P, Rahmouni A, Cherqui D, Zafrani ES, et al. Oral contraceptive use and focal nodular hyperplasia of the liver. Gastroenterology. 2000;118(3):560-4.

Katabathina VS, Menias CO, Shanbhogue AK, Jagirdar J, Paspulati RM, Prasad SR. Genetics and imaging of hepatocellular adenomas: 2011 update. Radiographics. 2011;31(6):1529-43.

Nault JC, Paradis V, Cherqui D, Vilgrain V, Zucman-Rossi J. Molecular classification of hepatocellular adenoma in clinical practice. J Hepatol. 2017;67(5):1074-83.

Jeffrey Jr RB, Tolentino CS, Chang FC, Federle MP. CT of small pyogenic hepatic abscesses: the cluster sign. Am J Roentgenol. 1988;151(3):487-9.

Laghi A, Iannaccone R, Rossi P, Carbone I, Ferrari R, Mangiapane F, Nofroni I, Passariello R. Hepatocellular carcinoma: detection with triple-phase multi–detector row helical CT in patients with chronic hepatitis. Radiology. 2003;226(2):543-9.

Tublin ME, Dodd 3rd GD, Baron RL. Benign and malignant portal vein thrombosis: differentiation by CT characteristics. Am J Roentgenol. 1997;168(3):719-23.

Ichikawa T, Federle MP, Grazioli L, Madariaga J, Nalesnik M, Marsh W. Fibrolamellar hepatocellular carcinoma: imaging and pathologic findings in 31 recent cases. Radiology. 1999;213(2):352-61.

Buetow PC, Buck JL, Pantongrag-Brown L, Ros PR, Devaney K, Goodman ZD, Cruess DF. Biliary cystadenoma and cystadenocarcinoma: clinical-imaging-pathologic correlations with emphasis on the importance of ovarian stroma. Radiology. 1995;196(3):805-10.

Miller WJ, Dodd 3rd GD, Federle MP, Baron RL. Epithelioid hemangioendothelioma of the liver: imaging findings with pathologic correlation. Am J Roentgenol. 1992;159(1):53-7.

Taouli B, Koh DM. Diffusion-weighted MR imaging of the liver. Radiology. 2010;254(1):47-66.

Ozturk A, Grajo JR, Dhyani M, Anthony BW, Samir AE. Principles of ultrasound elastography. Abd Radiol. 2018;43(4):773-85.

Sigrist RM, Liau J, El Kaffas A, Chammas MC, Willmann JK. Ultrasound elastography: review of techniques and clinical applications. Theranostics. 2017;7(5):1303.